Objective Nonpharmacological treatments are available for attention deficit hyperactivity
disorder (ADHD), although their efficacy remains uncertain. The authors undertook meta …

In paediatric medicine, drug doses are usually calculated individually based on the patient's
age, weight and clinical condition. Therefore, there are increased opportunities for, and a …

Objective: To systematically locate and review studies that have investigated the incidence
of medication errors (MEs) in pediatric inpatients and identify common errors. Methods: A …

Background The coronavirus disease 2019 (COVID-19) pandemic is having a profound
impact on the health and development of children worldwide. There is limited evidence on …

Objective Proton pump inhibitors (PPIs) is associated with worsening of gastric atrophy,
particularly in Helicobacter pylori (HP)-infected subjects. We determined the association …

Abstract Background Attention Deficit Hyperactivity Disorder (ADHD) is a common
neurodevelopmental disorder characterised by the symptoms of inattention, impulsivity and …

Objective To provide an overview of drug use in children in three European countries.
Design Retrospective cohort study, 2000-5. Setting Primary care research databases in the …

Background & Aims Use of dabigatran, an inhibitor of thrombin, increases the risk of
gastrointestinal bleeding (GIB). However, it is not clear whether gastroprotective agents …

Background The use of medications to treat attention deficit hyperactivity disorder (ADHD)
has increased, but the prevalence of ADHD medication use across different world regions is …

Preterm birth (PTB) is the leading cause of infant mortality worldwide. Changes in PTB rates,
ranging from− 90% to+ 30%, were reported in many countries following early COVID-19 …